Stemline Therapeutics Inc

We track 2 ClinicalTrials.gov studies led by Stemline Therapeutics Inc. The portfolio skews toward Phase 3 (1 trials).

2 clinical trials sponsored by Stemline Therapeutics Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
50%
Phase 2 1
50%

Trial Status Breakdown

Trials by Stemline Therapeutics Inc

Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase 3 Study

NCT06492616 · RECRUITING · Phase 3

An Open-label Multicenter Phase 1b-2 Study of Elacestrant in Combination With Abemaciclib in Women and Men With Brain Metastasis From Estrogen Receptor Positive, HER-2 Negative Breast Cancer

NCT05386108 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Stemline Therapeutics Inc sponsor?

Stemline Therapeutics Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 3, Phase 2.

What conditions does Stemline Therapeutics Inc research?

Stemline Therapeutics Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Stemline Therapeutics Inc recruiting for clinical trials?

Yes, Stemline Therapeutics Inc currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More